CNO Financial Files 8-K on Operations, Financial Condition
Ticker: CNO-PA · Form: 8-K · Filed: Feb 6, 2024 · CIK: 1224608
| Field | Detail |
|---|---|
| Company | Cno Financial Group, Inc. (CNO-PA) |
| Form Type | 8-K |
| Filed Date | Feb 6, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: financial-condition, operations, debt, securities-listing
TL;DR
**CNO Financial just filed an 8-K updating on operations and financial condition, confirming NYSE listings.**
AI Summary
CNO Financial Group, Inc. filed an 8-K on February 6, 2024, to report on its Results of Operations and Financial Condition, as well as Financial Statements and Exhibits. This filing confirms the company's current registered securities on the New York Stock Exchange, including its Common Stock (CNO), Rights to purchase Series E Junior Participating Preferred Stock, and 5.125% Subordinated Debentures due 2060 (CNOpA). This matters to investors as it provides an official update on the company's financial status and confirms the active trading of its various securities, which can influence market perception and liquidity.
Why It Matters
This filing provides an official update on CNO Financial Group's financial health and confirms the listing of its securities, offering transparency to investors.
Risk Assessment
Risk Level: low — This 8-K is a routine disclosure of financial condition and operations, not indicating any immediate new risks.
Analyst Insight
Investors should review the full financial statements and exhibits referenced in this 8-K to gain a deeper understanding of CNO Financial Group's current financial health and operational performance.
Key Numbers
- $0.01 — par value per share (par value of CNO Financial Group's Common Stock)
- 5.125% — interest rate (interest rate on CNO's Subordinated Debentures due 2060)
- 2060 — maturity year (maturity year for CNO's Subordinated Debentures)
Key Players & Entities
- CNO Financial Group, Inc. (company) — the registrant filing the 8-K
- New York Stock Exchange (company) — exchange where CNO's securities are registered
- $0.01 (dollar_amount) — par value per share of Common Stock
- February 6, 2024 (date) — date of earliest event reported and filing date
FAQ
What is the purpose of CNO Financial Group, Inc.'s 8-K filing dated February 6, 2024?
The 8-K filing by CNO Financial Group, Inc. on February 6, 2024, is to report on its Results of Operations and Financial Condition, as well as Financial Statements and Exhibits, as per Item 2.02 and Item 9.01 of Form 8-K.
What specific securities of CNO Financial Group, Inc. are registered on the New York Stock Exchange according to this filing?
According to the filing, the securities registered on the New York Stock Exchange are Common Stock, par value $0.01 per share (trading symbol CNO), Rights to purchase Series E Junior Participating Preferred Stock, and 5.125% Subordinated Debentures due 2060 (trading symbol CNOpA).
What is the par value of CNO Financial Group, Inc.'s Common Stock?
The par value of CNO Financial Group, Inc.'s Common Stock is $0.01 per share, as stated in the filing.
What is the interest rate and maturity year for CNO Financial Group, Inc.'s Subordinated Debentures mentioned in the filing?
The filing specifies that CNO Financial Group, Inc. has 5.125% Subordinated Debentures due 2060, indicating an interest rate of 5.125% and a maturity year of 2060.
What is the state of incorporation for CNO Financial Group, Inc.?
CNO Financial Group, Inc. is incorporated in Delaware, as indicated in the filing.
Filing Stats: 652 words · 3 min read · ~2 pages · Grade level 10.4 · Accepted 2024-02-06 16:28:37
Key Financial Figures
- $0.01 — ich registered Common Stock, par value $0.01 per share CNO New York Stock Exchange
Filing Documents
- cno-20240206.htm (8-K) — 31KB
- exhibit991-12312023earnings.htm (EX-99.1) — 782KB
- exhibit992-12312023investo.htm (EX-99.2) — 2257KB
- exhibit993.htm (EX-99.3) — 71KB
- cnologopra.jpg (GRAPHIC) — 47KB
- cnologosuppa.jpg (GRAPHIC) — 47KB
- exhibit993001.jpg (GRAPHIC) — 69KB
- exhibit993002.jpg (GRAPHIC) — 224KB
- exhibit993003.jpg (GRAPHIC) — 41KB
- exhibit993004.jpg (GRAPHIC) — 150KB
- exhibit993005.jpg (GRAPHIC) — 149KB
- exhibit993006.jpg (GRAPHIC) — 136KB
- exhibit993007.jpg (GRAPHIC) — 116KB
- exhibit993008.jpg (GRAPHIC) — 160KB
- exhibit993009.jpg (GRAPHIC) — 176KB
- exhibit993010.jpg (GRAPHIC) — 163KB
- exhibit993011.jpg (GRAPHIC) — 142KB
- exhibit993012.jpg (GRAPHIC) — 132KB
- exhibit993013.jpg (GRAPHIC) — 71KB
- exhibit993014.jpg (GRAPHIC) — 74KB
- exhibit993015.jpg (GRAPHIC) — 30KB
- exhibit993016.jpg (GRAPHIC) — 123KB
- exhibit993017.jpg (GRAPHIC) — 143KB
- exhibit993018.jpg (GRAPHIC) — 88KB
- exhibit993019.jpg (GRAPHIC) — 140KB
- exhibit993020.jpg (GRAPHIC) — 89KB
- exhibit993021.jpg (GRAPHIC) — 109KB
- exhibit993022.jpg (GRAPHIC) — 60KB
- exhibit993023.jpg (GRAPHIC) — 120KB
- exhibit993024.jpg (GRAPHIC) — 114KB
- exhibit993025.jpg (GRAPHIC) — 111KB
- exhibit993026.jpg (GRAPHIC) — 116KB
- exhibit993027.jpg (GRAPHIC) — 107KB
- exhibit993028.jpg (GRAPHIC) — 38KB
- exhibit993029.jpg (GRAPHIC) — 129KB
- exhibit993030.jpg (GRAPHIC) — 129KB
- exhibit993031.jpg (GRAPHIC) — 126KB
- exhibit993032.jpg (GRAPHIC) — 126KB
- exhibit993033.jpg (GRAPHIC) — 134KB
- exhibit993034.jpg (GRAPHIC) — 135KB
- exhibit993035.jpg (GRAPHIC) — 212KB
- exhibit993036.jpg (GRAPHIC) — 234KB
- exhibit993037.jpg (GRAPHIC) — 155KB
- exhibit993038.jpg (GRAPHIC) — 107KB
- exhibit993039.jpg (GRAPHIC) — 213KB
- exhibit993040.jpg (GRAPHIC) — 273KB
- exhibit993041.jpg (GRAPHIC) — 149KB
- exhibit993042.jpg (GRAPHIC) — 110KB
- exhibit993043.jpg (GRAPHIC) — 151KB
- exhibit993044.jpg (GRAPHIC) — 159KB
- exhibit993045.jpg (GRAPHIC) — 98KB
- exhibit993046.jpg (GRAPHIC) — 166KB
- 0001224608-24-000003.txt ( ) — 11862KB
- cno-20240206.xsd (EX-101.SCH) — 3KB
- cno-20240206_def.xml (EX-101.DEF) — 17KB
- cno-20240206_lab.xml (EX-101.LAB) — 34KB
- cno-20240206_pre.xml (EX-101.PRE) — 17KB
- cno-20240206_htm.xml (XML) — 5KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On February 6, 2024, CNO Financial Group, Inc. ("CNO" or the "Company") issued: (i) a press release announcing its financial results for the quarter ended December 31, 2023, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference; (ii) the Quarterly Financial Supplement for December 31, 2023, a copy of which is attached hereto as Exhibit 99.2 and is incorporated herein by reference; and (iii) additional financial information related to its financial and operating results for the quarter ended December 31, 2023, a copy of which is attached hereto as Exhibit 99.3 and is incorporated herein by reference. The information contained under Item 2.02 in this Current Report on Form 8-K (including Exhibits 99.1, 99.2 and 99.3) is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section. The information contained in this Current Report on Form 8-K shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing.
01(d). Financial Statements and Exhibits
Item 9.01(d). Financial Statements and Exhibits. The following materials are furnished as exhibits to this Current Report on Form 8-K: 99.1 Press release dated February 6, 2024 related to financial results for the quarter ended December 31, 2023. 99.2 Quarterly Financial Supplement - 4Q2023. 99.3 Fourth Quarter 2023 Financial and Operating Results for the period ended December 31, 2023. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CNO Financial Group, Inc. Date: February 6, 2024 By: /s/ Michellen Wildin Michellen Wildin Senior Vice President and Chief Accounting Officer 3